Drug giant Pfizer Inc. on Tuesday reported a loss for the fourth quarter as an increase in revenues was more than offset by higher charges, while the year-ago period's results were positively impacted by a hefty tax benefit. However, both revenue and adjusted earnings per share beat analysts' estimates. Looking ahead, the company forecast earnings and revenue for fiscal 2019 below expectations.
from RTT - Earnings http://bit.ly/2Ro9xzF
via IFTTT
No comments:
Post a Comment